TrialArthritis research & therapy2011

Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study.

Naomi Schlesinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.